汉字News

← 汉字NewsChinese News for Learners
life
shēng huó
生活
·HSK 4

study / research
yánjiū
研究
to show / to indicate
xiǎnshì
显示
，
GLP-1 receptor agonist drug class
GLP-1
GLP-1
drug / medication
yàowù
药物
may possibly / might
huò kě
或可
to reduce / to lower
jiàngdī
降低
depression
yìyù
抑郁
and
hé
和
anxiety
jiāolǜ
焦虑
worsening
èhuà
恶化
risk
fēngxiǎn
风险
。

one (study)
yī xiàng
一项
published in
fābiǎo zài
发表在
The Lancet Psychiatry journal
Liǔyèdāo Jīngshén Bìngxué
柳叶刀·精神病学
structural particle
de
的
study
yánjiū
研究
to find / to discover
fāxiàn
发现
，
GLP-1 receptor agonist drug class
GLP-1
GLP-1
type / class of
lèi
类
drug / medication
yàowù
药物
with / and
yǔ
与
psychiatric care
jīngshēnkē
精神科
to seek medical care
jiùzhěn
就诊
number of visits
cìshù
次数
to decrease
jiǎnshǎo
减少
42 percent
bǎifēnzhī sìshí èr
42%
to be associated with
xiāngguān
相关
。
researchers
yánjiū rényuán
研究人员
to analyze
fēnxī
分析
completion particle
le
了
Sweden
Ruìdiǎn
瑞典
nearly
jìn
近
nearly 100,000 (people)
shí wàn míng
十万名
patient
huànzhě
患者
structural particle
de
的
data
shùjù
数据
。

March 26, 2026 at 6:00 PM

one (study)
yī xiàng
一项
published in
fābiǎo zài
发表在
The Lancet Psychiatry journal
Liǔyèdāo Jīngshén Bìngxué
柳叶刀·精神病学
journal / magazine
zázhì
杂志
structural particle
de
的
study
yánjiū
研究
to show / to indicate
xiǎnshì
显示
，
GLP-1 receptor agonist drug class
GLP-1
GLP-1
receptor agonist
shòutǐ jīdòng jì
受体激动剂
type / class
lèi
类
drug / medication
yàowù
药物
possibly / may
kěnéng
可能
to help with / to benefit
yǒu zhù yú
有助于
to improve
gǎishàn
改善
patient
huànzhě
患者
structural particle
de
的
mental health
xīnlǐ jiànkāng
心理健康
。
researchers
yánjiū rényuán
研究人员
to analyze
fēnxī
分析
completion particle
le
了
Sweden
Ruìdiǎn
瑞典
nearly
jìn
近
nearly 100,000 (people)
shí wàn míng
十万名
patient
huànzhě
患者
structural particle
de
的
data
shùjù
数据
，
among them
qízhōng
其中
more than
chāoguò
超过
20,000 people
liǎng wàn rén
两万人
had used
shǐyòng guò
使用过
GLP-1 receptor agonist drug class
GLP-1
GLP-1
type / class
lèi
类
drug / medication
yàowù
药物
。
data
shùjù
数据
to show / to indicate
xiǎnshì
显示
，
to use
shǐyòng
使用
semaglutide medication
Sīměigélǔtài
司美格鲁肽
structural particle
de
的
patient
huànzhě
患者
depression disorder
yìyùzhèng
抑郁症
worsening
èhuà
恶化
risk
fēngxiǎn
风险
to reduce
jiàngdī
降低
completion particle
le
了
44 percent
bǎifēnzhī sìshísì
44%
，
anxiety
jiāolǜ
焦虑
worsening
èhuà
恶化
risk
fēngxiǎn
风险
to reduce
jiàngdī
降低
completion particle
le
了
38 percent
bǎifēnzhī sānshíbā
38%
。
in addition / furthermore
cǐwài
此外
，
this type of
gāi lèi
该类
drug / medication
yàowù
药物
also
hái
还
to cause / to make
shǐ
使
substance use disorder
wùzhì shǐyòng zhàng ài
物质使用障碍
structural particle
de
的
worsening
èhuà
恶化
risk
fēngxiǎn
风险
to reduce
jiàngdī
降低
completion particle
le
了
approximately
yuē
约
47 percent
bǎifēnzhī sìshíqī
47%
。
during use of
shǐyòng
使用
GLP-1 receptor agonist drug class
GLP-1
GLP-1
drug / medication
yàowù
药物
during the period
qījiān
期间
，
patient
huànzhě
患者
due to / because of
yīn
因
psychiatric care
jīngshēnkē
精神科
issue / problem
wèntí
问题
to seek medical treatment
jiùyī
就医
structural particle
de
的
number of visits
cìshù
次数
overall
zǒngtǐ
总体
to decrease
xiàjiàng
下降
completion particle
le
了
42 percent
bǎifēnzhī sìshí èr
42%
。
researchers
yánjiū rényuán
研究人员
to point out
zhǐchū
指出
，
semaglutide medication
Sīměigélǔtài
司美格鲁肽
and
hé
和
liraglutide medication
Lìlālǔtài
利拉鲁肽
to demonstrate / to show
xiǎnshì chū
显示出
positive
jījí
积极
effect / result
xiàoguǒ
效果
，
but / however
dàn
但
the other
lìngwài
另外
two types of
liǎng zhǒng
两种
GLP-1 receptor agonist drug class
GLP-1
GLP-1
drug / medication
yàowù
药物
did not show / no evidence of
wèi jiàn
未见
similar
lèisì
类似
effect / result
xiàoguǒ
效果
。
research team
yánjiū tuánduì
研究团队
to emphasize
qiángdiào
强调
，
this study
cǐcì
此次
result / finding
jiéguǒ
结果
to be classified as
shǔyú
属于
associative / correlational
guānlián xìng
关联性
finding / discovery
fāxiàn
发现
，
cannot yet
shàng wúfǎ
尚无法
to prove
zhèngmíng
证明
causal relationship
yīnguǒ guānxi
因果关系
，
at this stage
xiàn jiēduàn
现阶段
not recommended
bù jiànyì
不建议
to use as
jiāng
将
GLP-1 receptor agonist drug class
GLP-1
GLP-1
drug / medication
yàowù
药物
to use as
yòngzuò
用作
primary / main
zhǔyào
主要
structural particle
de
的
mental health
jīngshén jiànkāng
精神健康
treatment approach
zhìliáo shǒuduàn
治疗手段
。

News in English

Lifestyle & Culture

Study Finds GLP-1 Drugs May Lower Risk of Worsening Depression and Anxiety

A major study in The Lancet Psychiatry found GLP-1 receptor agonists like semaglutide were linked to a 42 percent reduction in psychiatric-related care. Researchers analyzed data from nearly 100,000 patients in Sweden.

More in Lifestyle & Culture

Arsenal (football club)
Āsēnnà
阿森纳
to advance into / to push forward to
tǐnɡjìn
挺进
UEFA Champions League
Ōuɡuàn
欧冠
final / championship match
juésài
决赛
，
to face / to compete against
duìzhèn
对阵
Paris Saint-Germain (PSG)
Bālí Shènɡ Rì'ěrmàn
巴黎圣日耳曼
。

Arsenal Reach Champions League Final to Face Paris Saint-Germain

NASA
Měiguó Hángtiānjú
美国航天局
Nancy Grace Roman (astronomer)
Nán Xī Gé Lěi Zī Luómàn
南希·格蕾丝·罗曼
space telescope
tàikōng wàngyuǎnjìng
太空望远镜
to launch
fāshè
发射
time / date
shíjiān
时间
moved up to / advanced to
tíqián zhì
提前至
September 2026
2026 nián 9 yuè
2026年9月
。

NASA Roman Space Telescope Launch Moved Up to September 2026

Novak Djokovic
Déyuē Kēwéiqí
德约科维奇
to advance / to qualify
jìnjí
晋级
French Open / Roland Garros
Fǎwǎng
法网
third round
dì sān lún
第三轮
，
will
jiāng
将
to face / to take on (in competition)
yíngzhàn
迎战
19-year-old
19 suì
19岁
structural particle
de
的
Joao Fonseca
Fēngsāikǎ
丰塞卡
。

Djokovic Reaches Roland Garros Round Three to Face 19-Year-Old Fonseca

United Kingdom
Yīngguó
英国
May
wǔyuè
五月
temperature / air temperature
qìwēn
气温
consecutive / in a row
liánxù
连续
two days
liǎng tiān
两天
to break (a record)
pò
破
historical record
lìshǐ jìlù
历史纪录
。

UK May Temperature Record Broken for Two Consecutive Days